OR4D1
gene geneOn this page
Also known as TPCR16
Summary
OR4D1 (olfactory receptor family 4 subfamily D member 1, HGNC:8293) is a protein-coding gene on chromosome 17q22, encoding Olfactory receptor 4D1 (Q15615). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 26689 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 30 total
- MANE Select transcript:
NM_001386095
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8293 |
| Approved symbol | OR4D1 |
| Name | olfactory receptor family 4 subfamily D member 1 |
| Location | 17q22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TPCR16 |
| Ensembl gene | ENSG00000141194 |
| Ensembl biotype | protein_coding |
| Entrez | 26689 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000268912, ENST00000641449
RefSeq mRNA: 2 — MANE Select: NM_001386095
NM_001386095, NM_012374
CCDS: CCDS42365
Canonical transcript exons
ENST00000268912 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000946972 | 58155135 | 58159585 |
| ENSE00003812578 | 58149429 | 58149796 |
| ENSE00003917667 | 58148384 | 58148584 |
| ENSE00003921400 | 58153857 | 58153963 |
Expression profiles
Bgee: expression breadth tissue_specific, 8 present calls, max score 63.37.
Top tissues by expression
216 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 63.37 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 58.21 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 57.88 | gold quality |
| skin of hip | UBERON:0001554 | 57.11 | silver quality |
| vena cava | UBERON:0004087 | 56.65 | gold quality |
| heart right ventricle | UBERON:0002080 | 56.15 | gold quality |
| sperm | CL:0000019 | 55.40 | gold quality |
| oocyte | CL:0000023 | 55.06 | gold quality |
| cardia of stomach | UBERON:0001162 | 52.04 | gold quality |
| lymph node | UBERON:0000029 | 50.65 | gold quality |
| blood | UBERON:0000178 | 49.37 | silver quality |
| stromal cell of endometrium | CL:0002255 | 48.55 | gold quality |
| lower lobe of lung | UBERON:0008949 | 46.14 | silver quality |
| subthalamic nucleus | UBERON:0001906 | 46.05 | gold quality |
| upper leg skin | UBERON:0004262 | 45.40 | silver quality |
| vastus lateralis | UBERON:0001379 | 45.13 | gold quality |
| quadriceps femoris | UBERON:0001377 | 45.01 | gold quality |
| caecum | UBERON:0001153 | 44.75 | silver quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 44.23 | gold quality |
| leukocyte | CL:0000738 | 43.97 | gold quality |
| bone marrow | UBERON:0002371 | 43.97 | gold quality |
| sural nerve | UBERON:0015488 | 43.76 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| trachea | UBERON:0003126 | 43.28 | gold quality |
| body of tongue | UBERON:0011876 | 43.11 | gold quality |
| vermiform appendix | UBERON:0001154 | 42.95 | gold quality |
| pylorus | UBERON:0001166 | 42.91 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 42.65 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| buccal mucosa cell | CL:0002336 | 42.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.01 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or4d1 | ENSMUSG00000060787 |
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR1A2 (ENSG00000172150), OR4C11 (ENSG00000172188), OR4X2 (ENSG00000172208), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200), OR4K17 (ENSG00000176230)
Protein
Protein identifiers
Olfactory receptor 4D1 — Q15615 (reviewed: Q15615)
Alternative names: Olfactory receptor 4D3, Olfactory receptor TPCR16
All UniProt accessions (1): Q15615
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (2): NP_001373024, NP_036506 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050427 | Olfactory_Receptors | Family |
Pfam: PF13853
UniProt features (22 total): topological domain 8, transmembrane region 7, sequence variant 2, sequence conflict 2, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q15615-F1 | 89.47 | 0.65 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 25 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, XU_GH1_AUTOCRINE_TARGETS_UP, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr17q22, XU_GH1_EXOGENOUS_TARGETS_UP, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
GO Biological Process (4): sensory perception of smell (GO:0007608), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of chemical stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
206 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR4D1 | CFAP77 | Q6ZQR2 | 507 |
| OR4D1 | SSMEM1 | Q8WWF3 | 506 |
| OR4D1 | ZNF280C | Q8ND82 | 445 |
| OR4D1 | KLHL36 | Q8N4N3 | 436 |
| OR4D1 | NT5DC1 | Q5TFE4 | 398 |
| OR4D1 | FAM114A2 | Q9NRY5 | 378 |
| OR4D1 | FBXW12 | Q6X9E4 | 370 |
| OR4D1 | LUZP1 | Q86V48 | 323 |
| OR4D1 | OXER1 | Q8TDS5 | 320 |
| OR4D1 | DNTTIP2 | Q5QJE6 | 311 |
| OR4D1 | DYRK4 | Q9NR20 | 302 |
| OR4D1 | FUT5 | Q11128 | 296 |
| OR4D1 | PABIR3 | Q6P4D5 | 277 |
| OR4D1 | ACOT11 | Q8WXI4 | 273 |
| OR4D1 | ZFAT | Q9P243 | 265 |
IntAct
0 interactions, top by confidence:
BioGRID (1): OR4D1 (Negative Genetic)
ESM2 similar proteins: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, P0C604, P0C623, P0C645, P0DN82, P58180, P58182, Q15615, Q60881, Q6IF82, Q8IXE1, Q8N0Y3, Q8NGA8, Q8NGB4, Q8NGB6, Q8NGC2, Q8NGC3, Q8NGD0, Q8NGD1, Q8NGD2, Q8NGD5, Q8NGE8, Q8NGF4, Q8NGF8, Q8NGF9, Q8NGI4, Q8NGI6, Q8NGJ0, Q8NGJ1, Q8NGL6, Q8NGM1, Q8NGN0, Q8NGN8, Q8NGX5, Q8NH05, Q8NH42, Q8NH49
Diamond homologs: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, O60412, O76099, O95013, P0C604, P0C623, P0C645, P0DN82, P23270, P23275, P58173, P58180, P58182, Q15615, Q60878, Q60881, Q60888, Q6IEV9, Q6IEY1, Q6IF82, Q7TQQ0, Q8IXE1, Q8N0Y3, Q8N628, Q8NGA8, Q8NGB2, Q8NGB4, Q8NGB6, Q8NGB8, Q8NGB9, Q8NGC2, Q8NGC3, Q8NGC4, Q8NGC6, Q8NGD0, Q8NGD1, Q8NGD2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
30 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
262 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:58155818:T:TA | acceptor_gain | 0.8300 |
| 17:58155808:A:AG | acceptor_gain | 0.8200 |
| 17:58155587:T:TA | donor_gain | 0.8000 |
| 17:58155588:A:AA | donor_gain | 0.8000 |
| 17:58155378:A:AG | acceptor_gain | 0.7900 |
| 17:58155379:G:GG | acceptor_gain | 0.7900 |
| 17:58155702:A:G | acceptor_gain | 0.7900 |
| 17:58155797:T:TA | acceptor_gain | 0.7200 |
| 17:58155809:C:G | acceptor_gain | 0.6700 |
| 17:58155658:TGTGG:T | acceptor_gain | 0.6500 |
| 17:58155808:ACT:A | acceptor_gain | 0.6500 |
| 17:58155660:TGG:T | acceptor_gain | 0.6400 |
| 17:58155807:T:G | acceptor_gain | 0.6400 |
| 17:58156143:T:G | acceptor_gain | 0.6400 |
| 17:58155660:T:TA | acceptor_gain | 0.6300 |
| 17:58155667:A:AG | acceptor_gain | 0.6300 |
| 17:58155814:ATCCT:A | acceptor_gain | 0.6300 |
| 17:58155483:G:GT | donor_gain | 0.6100 |
| 17:58155368:G:GT | acceptor_gain | 0.5800 |
| 17:58155806:ATACT:A | acceptor_gain | 0.5800 |
| 17:58155810:T:A | acceptor_gain | 0.5600 |
| 17:58155821:T:TA | acceptor_gain | 0.5600 |
| 17:58156142:AT:A | acceptor_gain | 0.5600 |
| 17:58155806:A:AG | acceptor_gain | 0.5500 |
| 17:58155476:G:GT | donor_gain | 0.5300 |
| 17:58155703:G:GG | acceptor_gain | 0.5300 |
| 17:58156142:A:AG | acceptor_gain | 0.5300 |
| 17:58155666:CAATA:C | acceptor_gain | 0.5000 |
| 17:58155819:G:A | acceptor_gain | 0.5000 |
| 17:58156141:C:G | acceptor_gain | 0.5000 |
AlphaMissense
2028 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:58155655:T:C | F168L | 0.918 |
| 17:58155657:C:A | F168L | 0.918 |
| 17:58155657:C:G | F168L | 0.918 |
| 17:58155187:T:C | F12L | 0.904 |
| 17:58155189:T:A | F12L | 0.904 |
| 17:58155189:T:G | F12L | 0.904 |
| 17:58155682:T:C | F177L | 0.903 |
| 17:58155684:C:A | F177L | 0.903 |
| 17:58155684:C:G | F177L | 0.903 |
| 17:58155904:T:C | F251L | 0.892 |
| 17:58155906:C:A | F251L | 0.892 |
| 17:58155906:C:G | F251L | 0.892 |
| 17:58155760:A:C | S203R | 0.836 |
| 17:58155762:T:A | S203R | 0.836 |
| 17:58155762:T:G | S203R | 0.836 |
| 17:58155188:T:G | F12C | 0.829 |
| 17:58155784:T:C | F211L | 0.828 |
| 17:58155786:C:A | F211L | 0.828 |
| 17:58155786:C:G | F211L | 0.828 |
| 17:58155598:T:A | W149R | 0.826 |
| 17:58155598:T:C | W149R | 0.826 |
| 17:58155973:A:C | S274R | 0.823 |
| 17:58155975:C:A | S274R | 0.823 |
| 17:58155975:C:G | S274R | 0.823 |
| 17:58155353:C:A | A67D | 0.801 |
| 17:58155518:G:C | R122P | 0.796 |
| 17:58155367:T:C | C72R | 0.784 |
| 17:58155453:G:C | Q100H | 0.777 |
| 17:58155453:G:T | Q100H | 0.777 |
| 17:58155937:T:C | F262L | 0.772 |
dbSNP variants (sampled 300 via entrez): RS1000323728 (17:58151366 A>G), RS1000460275 (17:58146834 G>C), RS1000554369 (17:58151968 A>G), RS1000652187 (17:58157020 T>C,G), RS1000794425 (17:58158786 T>G), RS1000915551 (17:58157236 C>G,T), RS1001055668 (17:58158557 G>A), RS1001261642 (17:58150020 T>C), RS1001382762 (17:58152541 C>T), RS1001564022 (17:58156254 C>A,T), RS1001624245 (17:58148937 T>C), RS1001859648 (17:58157359 C>A), RS1002124355 (17:58159398 G>A), RS1002966079 (17:58154380 A>G), RS1003102395 (17:58153937 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases mutagenesis | 2 |
| Cadmium Chloride | increases abundance, increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Malathion | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.